Life Sciences 2020: The Future is Here

In 2018, R&D spending in the

3

Corporate Research and Development Spending The biggest source of funding for the life sciences sector (but most difficult to track) is R&D spending by corporations, largely pharmaceutical companies. In 2018, R&D spending in the pharmaceuticals and life sciences industries totaled $154.5 billion, up from $148.7 billion in 2017 and a 40.0% increase since 2012. GLOBAL CORPORATE R&D SPEND: PHARMA, BIOTECH, LIFE SCIENCES

pharmaceuticals and life sciences industries totaled $154.5 billion, up from $148.7 billion in 2017 and a 40.0% increase since 2012.

110 120 130 140 150 160

Average Annual Growth Rate 2012-2019: 5.8% 2014-2017: 8.3%

Billions

2012 2013 2014 2015 2016 2017 2018

Source: Strategy&, PwC

Together, these three sources of capital invested an estimated $125 billion in 2018. TOTAL LIFE SCIENCES RESEARCH CAPITAL BY SOURCE

$0 $20,000 $40,000 $60,000 $80,000 $100,000 $120,000

Millions

2012 2013 2014 2015 2016 2017 2018 VC NIH Biopharma R&D

Source: Cushman & Wakefield Research

As capital has flowed into life sciences, employment has increased, leading to greater demand for lab and office space.

8 / CUSHMAN & WAKEFIELD